Skip Nav Destination
Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy:results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial
Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial
A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia
Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B study
ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia
Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations
Issue Archive
June 15 2007
In this Issue
Table of Contents
INSIDE BLOOD
PLENARY PAPERS
Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice
Elizabeth S. Raveche,Erica Salerno,Brian J. Scaglione,Vijaya Manohar,Fatima Abbasi,Yi-Chu Lin,Torgny Fredrickson,Pablo Landgraf,Sumant Ramachandra,Konrad Huppi,Jorge R. Toro,Vincent E. Zenger,Robert A. Metcalf,Gerald E. Marti
ERRATUM
REVIEW ARTICLES
REVIEW IN TRANSLATIONAL HEMATOLOGY
HOW I TREAT
CHEMOKINES, CYTOKINES, AND INTERLEUKINS
Gossypin, a pentahydroxy glucosyl flavone, inhibits the transforming growth factor beta-activated kinase-1-mediated NF-κB activation pathway, leading to potentiation of apoptosis, suppression of invasion, and abrogation of osteoclastogenesis
Ajaikumar B. Kunnumakkara,Asha S. Nair,Kwang Seok Ahn,Manoj K. Pandey,Zhengfang Yi,Mingyao Liu,Bharat B. Aggarwal
CLINICAL TRIALS AND OBSERVATIONS
Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy:results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial
Clinical Trials & Observations
Claude Gardin,Pascal Turlure,Thierry Fagot,Xavier Thomas,Christine Terre,Nathalie Contentin,Emmanuel Raffoux,Stephane de Botton,Cecile Pautas,Oumedaly Reman,Jean-Henri Bourhis,Pierre Fenaux,Sylvie Castaigne,Mauricette Michallet,Claude Preudhomme,Thierry de Revel,Dominique Bordessoule,Herve Dombret,for the Acute Leukemia French Association (ALFA)
Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801
Clinical Trials & Observations
Daniel J. DeAngelo,Daohai Yu,Jeffrey L. Johnson,Steven E. Coutre,Richard M. Stone,Alison T. Stopeck,Jon P. Gockerman,Beverly S. Mitchell,Frederick R. Appelbaum,Richard A. Larson
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial
Clinical Trials & Observations
Hagop Kantarjian,Ricardo Pasquini,Nelson Hamerschlak,Philippe Rousselot,Jerzy Holowiecki,Saengsuree Jootar,Tadeusz Robak,Nina Khoroshko,Tamas Masszi,Aleksander Skotnicki,Andrzej Hellmann,Andrey Zaritsky,Anatoly Golenkov,Jerald Radich,Timothy Hughes,Athena Countouriotis,Neil Shah
A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia
Clinical Trials & Observations
Jean-Luc Harousseau,Jeffrey E. Lancet,Josy Reiffers,Bob Lowenberg,Xavier Thomas,Francoise Huguet,Pierre Fenaux,Steven Zhang,Wayne Rackoff,Peter De Porre,Richard Stone,for the Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group,for the Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group,for the Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group,for the Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group,for the Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group,for the Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group,for the Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group,for the Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group,for the Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group,for the Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group,for the Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group
Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B study
Brief Report
Susan P. Whitman,Amy S. Ruppert,Guido Marcucci,Krzysztof Mrózek,Peter Paschka,Christian Langer,Claudia D. Baldus,Jing Wen,Tamara Vukosavljevic,Bayard L. Powell,Andrew J. Carroll,Jonathan E. Kolitz,Richard A. Larson,Michael A. Caligiuri,Clara D. Bloomfield
GENE THERAPY
Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene
Cary Hsu,Stephanie A. Jones,Cyrille J. Cohen,Zhili Zheng,Keith Kerstann,Juhua Zhou,Paul F. Robbins,Peter D. Peng,Xinglei Shen,Theotonius J. Gomes,Cynthia E. Dunbar,David J. Munroe,Claudia Stewart,Kenneth Cornetta,Danny Wangsa,Thomas Ried,Steven A. Rosenberg,Richard A. Morgan
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
The DC-SIGN–related lectin LSECtin mediates antigen capture and pathogen binding by human myeloid cells
Angeles Dominguez-Soto,Laura Aragoneses-Fenoll,Enrique Martin-Gayo,Lorena Martinez-Prats,Maria Colmenares,Marisa Naranjo-Gomez,Francesc E. Borras,Pilar Munoz,Mercedes Zubiaur,Maria L. Toribio,Rafael Delgado,Angel L. Corbi
NEOPLASIA
Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival
James R. Cerhan,Sophia Wang,Matthew J. Maurer,Stephen M. Ansell,Susan M. Geyer,Wendy Cozen,Lindsay M. Morton,Scott Davis,Richard K. Severson,Nathaniel Rothman,Charles F. Lynch,Sholom Wacholder,Stephen J. Chanock,Thomas M. Habermann,Patricia Hartge
ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia
Brief Report
Chiara Gregorj,Maria R. Ricciardi,Maria T. Petrucci,Maria C. Scerpa,Fabiana De Cave,Paola Fazi,Marco Vignetti,Antonella Vitale,Marco Mancini,Giuseppe Cimino,Salvatore Palmieri,Francesco Di Raimondo,Giorgina Specchia,Francesco Fabbiano,Nicola Cantore,Federico Mosna,Andrea Camera,Mario Luppi,Luciana Annino,Eustachio Miraglia,Giuseppe Fioritoni,Francesca Ronco,Giovanna Meloni,Franco Mandelli,Michael Andreeff,Michele Milella,Robin Foà,Agostino Tafuri,the GIMEMA Acute Leukemia Working Party, Italy
Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations
Brief Report
Kazuyuki Matsuda,Akira Shimada,Nao Yoshida,Atsushi Ogawa,Akihiro Watanabe,Shuhei Yajima,Susumu Iizuka,Kazutoshi Koike,Fumio Yanai,Keiichiro Kawasaki,Masakatsu Yanagimachi,Akira Kikuchi,Yoshitoshi Ohtsuka,Eiko Hidaka,Kazuyoshi Yamauchi,Miyuki Tanaka,Ryu Yanagisawa,Yozo Nakazawa,Masaaki Shiohara,Atsushi Manabe,Seiji Kojima,Kenichi Koike
RED CELLS
STEM CELLS IN HEMATOLOGY
TRANSPLANTATION
CORRESPONDENCE
-
Cover Image
Cover Image
"Water" by Giuseppe Arcimboldo (Italy, 1527-1593). Reproduced with the permission of the Kunsthistorisches Museum, Vienna, Austria. See the commentary by Migliaccio, page 5077, and the related article by Ferreira et al, page 5481.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals